Analystreport

CRISPR Therapeutics (NASDAQ:CRSP) was given a new $74.00 price target on by analysts at Chardan Capital.

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time